🔥🐔 BizChicken 🐔🔥
Companies Similar to Champions Oncology, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
ORIC Pharmaceuticals, Inc.
ORIC-533, ORIC-944, ORIC-114
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.
Symbol: ORIC
Recent Price: $8.17
Industry: Biotechnology
CEO: Dr. Jacob M. Chacko M.B.A., M.D.
Sector: Healthcare
Employees: 107
Address: 240 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 388 5600
Last updated: 2024-12-31
Acrivon Therapeutics, Inc. Common Stock
Acrivon Predictive Precision Proteomics
Acrivon Therapeutics is a clinical stage biopharmaceutical company developing oncology medicines using a proteomics-based platform to identify patient responders. Their lead candidate, ACR-368, is in Phase 2 trials for various cancers.
Symbol: ACRV
Recent Price: $5.41
Industry: Biotechnology
CEO: Dr. Peter Blume-Jensen M.D., Ph.D.
Sector: Healthcare
Employees: 58
Address: 480 Arsenal Way, Watertown, MA 02472
Phone: 617-207-8979
Last updated: 2024-12-31
Agenus Inc.
Retrocyte Display
Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.
Symbol: AGEN
Recent Price: $2.69
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 389
Address: 3 Forbes Road, Lexington, MA 02421-7305
Phone: 781 674 4400
Last updated: 2024-12-31
Allogene Therapeutics, Inc.
UCART19
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer.
About | About | About | Contact | Contact | Careers | Careers | Jobs | About | About | About | About | About | About
Symbol: ALLO
Recent Price: $2.10
Industry: Biotechnology
CEO: Dr. David D. Chang M.D., Ph.D.
Sector: Healthcare
Employees: 232
Address: 210 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 457 2700
Last updated: 2024-12-31
ALX Oncology Holdings Inc.
ALX148
ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company developing therapies for cancer patients. Its lead product, ALX148, targets CD47 and is in trials for various cancers. The company also explores pre-clinical treatments like ALTA-002 to enhance immune response to cancer.
About | Contact | About | About | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Careers | About | About | Careers | Jobs
Symbol: ALXO
Recent Price: $1.66
Industry: Biotechnology
CEO: Mr. Jason W. Lettmann
Sector: Healthcare
Employees: 81
Address: 323 Allerton Avenue, South San Francisco, CA 94080
Phone: 650 466 7125
Last updated: 2024-12-31
American Oncology Network, Inc.
Oncology Services
American Oncology Network, Inc. provides comprehensive oncology services, including laboratory, pathology, specialty pharmacy, and care management support services in the United States.
Symbol: AONC
Recent Price: $4.94
Industry: Medical - Care Facilities
CEO: Mr. Todd Schonherz
Sector: Healthcare
Employees: 1525
Address: 14543 Global Parkway, Fort Myers, FL 33913
Phone: 833-886-1725
Last updated: 2024-12-31
Celularity Inc.
CYCART-19, CYNK-001, CYNK-101, APPL-001, PDA-002
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and Bio Banking.
About | Leadership | Directors | About | About | About | About | Directors | Careers | About | About | About | About | About | About
Symbol: CELU
Recent Price: $2.05
Industry: Biotechnology
CEO: Dr. Robert Joseph Hariri M.D., Ph.D.
Sector: Healthcare
Employees: 120
Address: 170 Park Avenue, Florham Park, NJ 07932
Phone: 908 768 2170
Leadership
- Robert J. Hariri, M.D., Ph.D., Chairperson, Founder, and CEO
- David Beers, CFA, Chief Financial Officer
- Stephen Brigido, DPM, President, Degenerative Diseases
- John Haines, Global Manager and Chief Administrative Officer
- K. Harold Fletcher, Esq., General Counsel & Chief Compliance Officer
- John Colerangle, DVM, Ph.D., Regulatory Affairs
- Anna Gosiewska, Ph.D., R&D, Degenerative Diseases
- Sharmila Koppisetti, M.D., Clinical Development Immunology & Drug Safety
- Carmine Palummo, Corporate Operations
- Tim Wilk, Technical Operations
- Robert J. Hariri, M.D., Ph.D, Chairperson, Founder & CEO
- Peter Diamandis, M.D., Director
- Dean Kehler, Director
- Geoffrey Shiu Fei Ling, M.D., Ph.D., Director
- Diane Parks, Director
Last updated: 2024-12-31
Champions Oncology, Inc.
Tumorgraft Technology Platform
Champions Oncology, Inc. specializes in personalized cancer care technology solutions, including the Tumorgraft Technology Platform and Lumin Bioinformatics, aimed at enhancing oncology drug development and usage.
Symbol: CSBR
Recent Price: $8.62
Industry: Biotechnology
CEO: Dr. Ronnie Morris M.D.
Sector: Healthcare
Employees: 210
Address: One University Plaza, Hackensack, NJ 07601
Phone: 201 808 8400
Last updated: 2024-12-31
Foghorn Therapeutics Inc.
Gene Traffic Control platform
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. It utilizes its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system.
Symbol: FHTX
Recent Price: $4.61
Industry: Biotechnology
CEO: Mr. Adrian H. B. Gottschalk
Sector: Healthcare
Employees: 116
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 586 3100
Leadership
- Steven Bellon, PHD, Chief Scientific Officer
- Carlos Costa, Chief People Officer
- Danette Daniels, PHD, VP, Protein Degrader Platform
- Dan Dinu, MBA, VP, Information Technology
- Michael Garcia-Webb, PHD, VP, Chief of Staff Research
- Andrew Germain, PHD, VP, Legal
- Adrian Gottschalk, President & CEO
- Chong-Hui Gu, PHD, VP, CMC and QA
- Karin Hellsvik, Chief of Staff to the CEO Vice President, Corporate Affairs and Investor Relations
- Murphy Hentemann, PHD, VP, Program Leadership
- Kristian Humer, MBA, Chief Financial Officer
- Michael LaCascia, Chief Legal Officer
- Marina Nelen, PhD, VP, Drug Discovery
- Alfonso Quintás-Cardama, MD, Chief Medical Officer
- Alena Reva, VP, Total Rewards & People Operations
- Anna Rivkin, PHD, Chief Business Officer
- Saurabh Sewak, PHD, VP, Corporate Development
- Gromek Smolen, PHD, VP, Biology
- Kevin Wilson, PHD, VP, Chemistry
- José Baselga MD, PhD, In Memoriam
- Scott Biller, PHD, Strategic Advisor, Agios Pharmaceuticals
- Doug Cole, MD, Founder, Foghorn Therapeutics Managing Partner, Flagship Pioneering
- Simba Gill, PhD, Former President & CEO, Evelo Biosciences
- Cigall Kadoch, PhD, Scientific Advisor to the Board of Directors; Founder, Foghorn Therapeutics
- Adam Koppel, MD, PhD, Managing Director, Bain Capital Life Sciences
- Tom Lynch, MD, President and Director, Fred Hutchinson Cancer Center
- Michael Mendelsohn, MD, Chairman & Founder, Cardurion Pharmaceuticals
- Lynne Parshall, Senior Strategic Advisor, Ionis Pharmaceuticals
- Ian Smith, Chairman of the Board, Solid BioSciences
- Gerald Crabtree, MD, Founder, Foghorn Therapeutics David Korn Professor, Stanford University Medical School Investigator, Howard Hughes Medical Institute
- Tony Kouzarides, PhD, FMedSci, FRS, Professor of Cancer Biology at the University of Cambridge Director of the Milner Therapeutics Institute and Deputy Director of the Gurdon Institute
- Charles Sawyers, MD, Investigator, Howard Hughes Medical Institute Marie-Josée and Henry Kravis Chair in Human Oncology and Pathogenesis and Chairman, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center; SAB Chair
- David Schenkein, MD, General Partner, Co-leader, Google Ventures life science team Former CEO, Agios
Last updated: 2024-12-31
Imunon, Inc.
GEN-1, Thermo Dox
Imunon, Inc. is a clinical stage biotechnology company specializing in the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies, focusing on products such as GEN-1 for ovarian cancer and Thermo Dox for various cancer indications.
About | Leadership | About | About | About | About | About | Leadership | Contact | Contact | About
Symbol: IMNN
Recent Price: $0.82
Industry: Biotechnology
CEO: Dr. Stacy R. Lindborg Ph.D.
Sector: Healthcare
Employees: 33
Address: 997 Lenox Drive, Lawrenceville, NJ 08648
Phone: 609 896 9100
Leadership
- Stacy R. Lindborg, PhD, President, Chief Executive Officer, and Board Director
- David Gaiero, Chief Financial Officer
- Khursheed Anwer, PhD, MBA, Executive Vice President and Chief Science Officer
- Kristin Longobardi, MBA, Senior Vice President, Strategic Operations
- Susan Eylward, General Counsel and Corporate Secretary
- Michael H. Tardugno,
- Frederick J. Fritz,
- Donald Braun, PhD,
- Christine Pellizzari, JD,
- James E. Dentzer,
Last updated: 2024-12-31
Legend Biotech Corporation
LCAR-B38M
Legend Biotech Corporation is a clinical-stage biopharmaceutical company focusing on the discovery and development of novel cell therapies for oncology and other indications globally.
About | Our Story | Leadership | About | About | Contact | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Careers | About | About
Symbol: LEGN
Recent Price: $32.77
Industry: Biotechnology
CEO: Dr. Ying Huang Ph.D.
Sector: Healthcare
Employees: 2200
Address: 2101 Cottontail Lane, Somerset, NJ 08873
Phone: 732 317 5050
Leadership
- Ying Huang, Ph.D., CHIEF EXECUTIVE OFFICER
- Guowei Fang, Ph.D., CHIEF SCIENTIFIC OFFICER AND HEAD OF BUSINESS DEVELOPMENT
- Lori Macomber, CHIEF FINANCIAL OFFICER
- Mythili Koneru, M.D., Ph.D., CHIEF MEDICAL OFFICER
- Jim Pepin, GENERAL COUNSEL
- Steve Gavel, SENIOR VICE PRESIDENT, COMMERCIAL DEVELOPMENT, US & EUROPE
- Yuhong Qiu, Ph.D., SENIOR VICE PRESIDENT, GLOBAL REGULATORY AFFAIRS
- Birk Vanderweeën, SENIOR VICE PRESIDENT, GLOBAL MANUFACTURING & SUPPLY
- Alan Kick, SENIOR VICE PRESIDENT, GLOBAL QUALITY
- Doug Wallace, VICE PRESIDENT, GLOBAL OPERATIONS
- Elaine Qian, VICE PRESIDENT, GLOBAL HEAD OF HUMAN RESOURCES
- Tim Roberts, Global Compliance Officer
- Simon Wu, Senior Vice President, General Manager, Greater China
- Frank Zhang, EMBA, Ph.D., CHAIRMAN OF THE BOARD, LEGEND BIOTECH
- Sally Wang, M.S., PRESIDENT, GENSCRIPT
- Zhu Li, Ph.D., CHIEF STRATEGY OFFICER, GENSCRIPT
- Corazon (Corsee) Dating Sanders, Ph.D., CO-CHAIR OF THE BOARD OF ADVISORS, FRED HUTCH CANCER CENTER
- Darren Ji, M.D., Ph.D. and MBA, CHAIRMAN AND CEO, ELPISCIENCE BIOPHARMACEUTICALS
- Philip Yau, CHIEF FINANCIAL OFFICER. C&J CLARK
- Patrick Casey, Ph.D., SENIOR VICE DEAN OF RESEARCH, DUKE-NUS MEDICAL SCHOOL SINGAPORE AND A JAMES B. DUKE PROFESSOR OF PHARMACOLOGY AND CANCER BIOLOGY, DUKE UNIVERSITY
- Tomas J. Heyman, CEO, INTERLAKEN THERAPEUTICS
- Li Mao, M.D., CHIEF MEDICAL OFFICER, SCICLONE PHARMACEUTICALS
- Peter Salovey, Ph.D., Chris Argyris Professor of Psychology; Professor of Management, Epidemiology & Public Health, and Sociology; and President Emeritus of Yale University
- Michel Vounatsos, FORMER CEO OF BIOGEN INC.
- John Maraganore, Ph.D., FORMER CEO OF ALNYLAM PHARMACEUTICALS
Last updated: 2024-12-31
Predictive Oncology Inc.
Personalized Cancer Therapies
Predictive Oncology Inc. is a knowledge-driven company focusing on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States, operating in four segments: Helomics, z PREDICTA, Soluble, and Skyline.
Symbol: POAI
Recent Price: $0.90
Industry: Medical - Instruments & Supplies
CEO: Mr. Raymond F. Vennare
Sector: Healthcare
Employees: 34
Address: 2915 Commers Drive, Eagan, MN 55121
Phone: 651 389 4800
Last updated: 2024-12-31
Personalis, Inc.
NeXT Platform
Personalis, Inc. is a cancer genomics company that provides sequencing and data analysis services for cancer therapy development and genetic research. Their products include NeXT Platform, NeXT Liquid Biopsy, NeXT Personal, NeXT Dx Test, and ACE platform, serving biopharmaceutical, academic, and government institutions.
About | Contact | Contact | Contact | Careers | Careers | Careers | About | About | Careers | About | About | About
Symbol: PSNL
Recent Price: $5.97
Industry: Medical - Diagnostics & Research
CEO: Mr. Christopher M. Hall
Sector: Healthcare
Employees: 223
Address: 1330 O’Brien Drive, Menlo Park, CA 94025
Phone: 650 752 1300
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
Alaunos Therapeutics, Inc.
Adoptive TCR Engineered T-cell Therapies
Alaunos Therapeutics is a clinical-stage company focused on developing cell therapies for cancer treatment, utilizing TCR engineered T-cell therapies in clinical trials for various cancers.
Symbol: TCRT
Recent Price: $2.17
Industry: Biotechnology
CEO: Mr. Dale Curtis Hogue Jr.
Sector: Healthcare
Employees: 1
Address: 8030 El Rio Street, Houston, TX 77054
Phone: 346 355 4099
Last updated: 2024-12-31
Cullinan Oncology, Inc.
CLN-081
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. Their lead candidate, CLN-081, is in a trial for treating non-small cell lung cancer. The company also has several preclinical products targeting various forms of cancer.
Symbol: CGEM
Recent Price: $12.20
Industry: Biotechnology
CEO: Mr. Nadim Ahmed
Sector: Healthcare
Employees: 85
Address: One Main Street, Cambridge, MA 02142
Phone: 617 410 4650
Last updated: 2024-12-31
Marker Therapeutics, Inc.
Multi TAA-specific T cell technology
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company developing T cell-based immunotherapies and peptide-based vaccines for treating hematological malignancies and solid tumors in the US.
Contact | About | Management | Directors | About | Contact | Contact | Careers | About | About
Symbol: MRKR
Recent Price: $3.34
Industry: Biotechnology
CEO: Dr. Juan F. Vera M.D.
Sector: Healthcare
Employees: 8
Address: 3200 Southwest Freeway, Houston, TX 77027
Phone: 713 400 6400
Leadership
- David Eansor, President, Protein Sciences Segment, Bio-Techne Corporation
- Steve Elms, Managing Partner, Aisling Capital
- John R. Wilson, CEO, Wilson Wolf Manufacturing, Co-Founder Marker Therapeutics, Co-Founder AlloVir
- Juan F. Vera, Chief Executive Officer & Co-Founder, Marker Therapeutics, Co-Founder, AlloVir
- Katharine Knobil, M.D., Chief Medical Officer at Agilent Technologies, Inc.
Last updated: 2024-12-31
Orgenesis Inc.
Point of Care (POCare) platform
Orgenesis Inc. is a biotech company focusing on cell and gene therapies. It offers a Point of Care (POCare) platform with a pipeline of POCare therapeutics produced in automated systems, targeting autologous therapies near the patient's point of care.
About | Contact | Careers | Careers | Careers | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | News | Careers | Directors | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: ORGS
Recent Price: $2.11
Industry: Biotechnology
CEO: Ms. Vered Caplan M.Sc.
Sector: Healthcare
Employees: 146
Address: 20271 Goldenrod Lane, Germantown, MD 20876
Phone: 480 659 6404
Last updated: 2024-12-31
The Oncology Institute, Inc.
Medical Oncology Services
An oncology company providing medical oncology services in the United States, including clinical trials, radiation, outpatient stem cell transplants, and patient support, serving adult and senior cancer patients with 67 clinic locations.
About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: TOI
Recent Price: $0.32
Industry: Medical - Care Facilities
CEO: Dr. Daniel Virnich FACHE, M.B.A., M.D.
Sector: Healthcare
Employees: 800
Address: 18000 Studebaker Road, Cerritos, CA 90703
Phone: 213 760 1328
Last updated: 2024-12-31
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31